Clinical Trials

If you are interested in participating in our research, please click here to take a brief survey.

Current Clinical Research Projects at our Clinic

Janssen
Protocol : JNJ-54861911
Patients : 60 to 85 years old
Diagnostic : Subjects asymptomatic but At Risk for developing Alzheimer’s Dementia
Agent : Beta amyloid cleaving enzyme inhibitor
Daily oral administration

Eisai

Protocol: E2609-G000-302

Patients: 50 to 85 years old

Diagnostic: MCI/Alzheimer’s Disease

Agent: Beta amyloid cleaving enzyme inhibitor

Daily oral administration

TTP
Protocol: TTP488-301
Patients : 50 years old or older
Diagnostic : Alzheimer’s Disease
Agent : Antagonist at the Receptor for Advanced Glycation End products (RAGE)
Daily oral administration

MERCK
Protocol: MK-8931-019
Patients: 50 to 85 years old
Diagnostic: MCI / Prodromal Alzheimer’s Disease
Agent: Beta amyloid cleaving enzyme inhibitor
Daily oral administration